Literature DB >> 8674361

Anal fistula surgery. Factors associated with recurrence and incontinence.

J Garcia-Aguilar1, C Belmonte, W D Wong, S M Goldberg, R D Madoff.   

Abstract

PURPOSE: This study was undertaken to assess results of surgery for fistula-in-ano and identify risk factors for fistula recurrence and impaired continence.
METHODS: We reviewed the records of 624 patients who underwent surgery for fistula-in-ano between 1988 and 1992. Follow-up was by mailed questionnaire, with 375 patients (60 percent) responding. Mean follow-up was 29 months. Fistulas were intersphincteric in 180 patients, transsphincteric in 108, suprasphincteric in 6, extrasphincteric in 6, and unclassified in 75. Procedures included fistulotomy and marsupialization (n = 300), seton placement (n = 63), endorectal advancement flap (n = 3), and other (n = 9). Factors associated with recurrence and incontinence were analyzed by univariate and multivariate regression analysis.
RESULTS: The fistula recurred in 31 patients (8 percent), and 45 percent complained of some degree of postoperative incontinence. Factors associated with recurrence included complex type of fistula, horseshoe extension, lack of identification or lateral location of the internal fistulous opening, previous fistula surgery, and the surgeon performing the procedure. Incontinence was associated with female sex, high anal fistula, type of surgery, and previous fistula surgery.
CONCLUSIONS: Surgical treatment of fistula-in-ano is associated with a significant risk of recurrence and a high risk of impaired continence. Degree of risk varies with identifiable factors.

Entities:  

Mesh:

Year:  1996        PMID: 8674361     DOI: 10.1007/bf02054434

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  90 in total

1.  Ligation of the intersphincteric fistula tract (LIFT) to treat anal fistula: early results from a prospective observational study.

Authors:  P Sileri; L Franceschilli; G P Angelucci; S D'Ugo; G Milito; F Cadeddu; I Selvaggio; S Lazzaro; A L Gaspari
Journal:  Tech Coloproctol       Date:  2011-11-11       Impact factor: 3.781

Review 2.  Evaluation and management of perianal abscess and anal fistula: a consensus statement developed by the Italian Society of Colorectal Surgery (SICCR).

Authors:  A Amato; C Bottini; P De Nardi; P Giamundo; A Lauretta; A Realis Luc; G Tegon; R J Nicholls
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

3.  Anal endosonography and fistulography for fistula-in-ano.

Authors:  F Pomerri; G Dodi; G Pintacuda; L Amadio; P C Muzzio
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

Review 4.  Controversies in the treatment of common anal problems.

Authors:  Ismail Sagap; Feza-H Remzi
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

5.  Acute abscess with fistula: long-term results justify drainage and fistulotomy.

Authors:  E B Benjelloun; A Jarrar; K El Rhazi; T Souiki; A Ousadden; K Ait Taleb
Journal:  Updates Surg       Date:  2013-06-20

Review 6.  Short-term efficacy and safety of three novel sphincter-sparing techniques for anal fistulae: a systematic review.

Authors:  S O Adegbola; K Sahnan; G Pellino; P J Tozer; A Hart; R K S Phillips; J Warusavitarne; O D Faiz
Journal:  Tech Coloproctol       Date:  2017-10-29       Impact factor: 3.781

7.  Permacol™ collagen paste injection for the treatment of complex anal fistula: 1-year follow-up.

Authors:  B Fabiani; C Menconi; J Martellucci; I Giani; G Toniolo; G Naldini
Journal:  Tech Coloproctol       Date:  2017-02-16       Impact factor: 3.781

8.  The contribution of preoperative MRI to the surgical management of anal fistulas.

Authors:  Ali Konan; Mehmet Ruhi Onur; Mustafa Nasuh Özmen
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

9.  Perianal abscess/fistula disease.

Authors:  Mark H Whiteford
Journal:  Clin Colon Rectal Surg       Date:  2007-05

10.  [Fecal incontinence].

Authors:  J Braun; S Willis
Journal:  Chirurg       Date:  2004-09       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.